Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
GlobeNewswire Inc.
1 hours ago
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants with chronic kidney disease – – In participants with chronic kidney disease and baseline albuminu
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
GlobeNewswire Inc.
5 hours ago
WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival data from the
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire Inc.
5 hours ago
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50, CI: 0.39-0.65, p<0.0001) for bezuclastinib combinat
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
GlobeNewswire Inc.
5 hours ago
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built p
Atlantico Energy Metals Corp. Announces Closing of Amalgamation Transaction and Conditional Approval for Listing on the CSE
Newsfile
13 hours ago
West Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Atlantico Energy Metals Corp. (formerly Magnum Goldcorp Inc.) (the "Company" or "Atlantico") is pleased to announce that further to its press releases dated June 23, 2025, October 28
Good Purpose Investments Announces Frankfurt Stock Exchange Listing and Engages Global One Media
Newsfile
16 hours ago
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Good Purpose Investments Inc. (CSE: GPIN) (FSE: 8BS) ("GPI" or the "Company") is pleased to announce that its common shares (the "Common Shares") have commenced trading on the Frankfurt S
Global Compliance Completes Acquisition of Global People's Trust
Newsfile
16 hours ago
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Global Compliance Applications Corp. (CSE: APP) (FSE: 2FA) (OTCQB: FUAPF) ("GCAC" or the "Company") is pleased to announce that, further to the Company's news release dated March 9, 2026,
Toogood Gold Signs Definitive Agreement for Option to Earn 100% Interest in the Table Mountain Project, Nevada
Newsfile
16 hours ago
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Toogood Gold Corp. (TSXV: TGC) (OTCQB: TGGCF) (FSE: D3P) ("Toogood" or the "Company") today announced that it has entered into a definitive option agreement (the "Definitive Agreement") d
The FUTR Corporation Reports Financial Results for Q1 2026
Newsfile
16 hours ago
Three-Month Period Ended March 31, 2026Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - The FUTR Corporation (TSXV: FTRC) (OTCQB: FTRCF) (FSE: QA20), creator of the FUTR Agent App which enables users to store, manage, access, and monetize their pe
Canadian Goldfields Appoints Harp Gosal as Director of Capital Markets and Communications
Newsfile
Yesterday at 11:56 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2026) - Canadian Goldfields Discovery Corp. (TSXV: CGM) (OTCQB: CGMXF) ("Canadian Goldfields" or the "Company") is pleased to announce the appointment of Harp Gosal as Director of Capital Markets

